Menu
/REGISTER
Montecito
Tolman Wiker
Pac Premier
Fielding
Farmers merchants
Nixon Peabody
Express Pros
Loading...
You are here:  Home  >  Health Care  >  Current Article

European Union approves Amgen’s Xgeva to treat multiple myeloma

By   /   Tuesday, April 3rd, 2018  /   Comments Off on European Union approves Amgen’s Xgeva to treat multiple myeloma

    Print       Email
Amgen’s Xgeva received European Commission approval April 3 to treat patients with multiple myeloma, following a similar decision from the U.S. Food and Drug Administration in January. The approval of the drug, which prevents bone degeneration, uses data from a phase 3 study of skeletal-related events in multiple myeloma patients, the largest such international study…

Subscribe

    This article is only available to Business Times subscribers
  • Subscribers: LOG IN or REGISTER for complete digital access.
  • Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
  • Check the STATUS of your Subscription Account.
    Print       Email

You might also like...

Amgen CFO retiring in 2020

Read More →